104 related articles for article (PubMed ID: 38764200)
1. Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na
Jin H; Wen G; Zhu J; Liu J; Li J; Yao S; Zhao Z; Dong Z; Zhang X; An J; Liu X; Tuo B
Drug Dev Res; 2024 Jun; 85(4):e22198. PubMed ID: 38764200
[TBL] [Abstract][Full Text] [Related]
2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
3. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
5. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
6. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
8. Diethylnitrosamine-induced liver tumorigenesis in mice.
Schulien I; Hasselblatt P
Methods Cell Biol; 2021; 163():137-152. PubMed ID: 33785162
[TBL] [Abstract][Full Text] [Related]
9. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
10. iPLA2β-Null Mice Show HCC Protection by an Induction of Cell-Cycle Arrest after Diethylnitrosamine Treatment.
Andrade A; Poth T; Brobeil A; Merle U; Chamulitrat W
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430237
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
[TBL] [Abstract][Full Text] [Related]
12. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.
Ip BC; Hu KQ; Liu C; Smith DE; Obin MS; Ausman LM; Wang XD
Cancer Prev Res (Phila); 2013 Dec; 6(12):1304-16. PubMed ID: 24085778
[TBL] [Abstract][Full Text] [Related]
13. Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Sharma A; Ranvir R; Kadam S; Ingale K; Patel H; Nyska A; Jain MR
BMC Cancer; 2023 Jan; 23(1):59. PubMed ID: 36650455
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid.
Lau HC; Zhang X; Ji F; Lin Y; Liang W; Li Q; Chen D; Fong W; Kang X; Liu W; Chu ES; Ng QW; Yu J
EBioMedicine; 2024 Feb; 100():104952. PubMed ID: 38176203
[TBL] [Abstract][Full Text] [Related]
15. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
16. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.
Zimmers TA; Jin X; Gutierrez JC; Acosta C; McKillop IH; Pierce RH; Koniaris LG
J Cancer Res Clin Oncol; 2008 Jul; 134(7):753-9. PubMed ID: 18210153
[TBL] [Abstract][Full Text] [Related]
18. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
